FDA Approves Jemperli for Locally Advanced Rectal Cancer
GSK received U.S. FDA approval for Jemperli (dostarlimab) for adults with MSI-H/dMMR locally advanced rectal cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.